OMX Nordic 40
2.525,59
PKT
+16,64
PKT
+0,66
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.02.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 22.02.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.02.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.02.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 06.02.24 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 06.02.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.02.24 | Volvo (B) Sell | UBS AG | |
| 05.02.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 03.02.24 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 03.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 02.02.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.02.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.02.24 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 01.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 01.02.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 01.02.24 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 01.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 31.01.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 31.01.24 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 31.01.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 31.01.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 31.01.24 | AstraZeneca Sell | UBS AG |